Nabil M. Yazgi
Corporate Officer/Principal chez American Academy of Neurology
Profil
Nabil M.
Yazgi is a member of the American Academy of Neurology and the Neurological Association of New Jersey.
He previously worked as a Director at Camp Nine, Inc. and Relmada Therapeutics, Inc. He also served as an Independent Class I Director at Relmada Therapeutics, Inc. from 2014 to 2015.
Dr. Yazgi earned a doctorate degree from Damascus University in 1985.
Currently, he holds positions at the American Academy of Neurology and the Neurological Association of New Jersey.
Postes actifs de Nabil M. Yazgi
| Sociétés | Poste | Début |
|---|---|---|
American Academy of Neurology
 American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services American Academy of Neurology operates a professional society which represents neurologists and neuroscientists. The company was founded in 1948 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | - |
| Neurological Association of New Jersey | Corporate Officer/Principal | - |
Anciens postes connus de Nabil M. Yazgi
| Sociétés | Poste | Fin |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 06/11/2015 |
Relmada Therapeutics, Inc. /Old/
 Relmada Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Relmada Therapeutics, Inc. is a holding company, which engages in the development of pharmaceutical drugs for the treatment of acute and chronic pains. It focuses in the developing of chronic pain due to cancer, musculoskeletal disorders, and peripheral neuropathy. The company was founded in 2000 and is headquartered in Blue Bell, PA. | Directeur/Membre du Conseil | - |
Camp Nine, Inc.
 Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Camp Nine, Inc. operates as a clinical stage biopharmaceutical company. The company through its subsidiary Relmada Therapeutics, Inc. focused on developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. Camp Nine was founded on May 31, 2012 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Formation de Nabil M. Yazgi
| Damascus University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RELMADA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Camp Nine, Inc.
Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Camp Nine, Inc. operates as a clinical stage biopharmaceutical company. The company through its subsidiary Relmada Therapeutics, Inc. focused on developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. Camp Nine was founded on May 31, 2012 and is headquartered in New York, NY. | Health Technology |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services American Academy of Neurology operates a professional society which represents neurologists and neuroscientists. The company was founded in 1948 and is headquartered in Minneapolis, MN. | Commercial Services |
Relmada Therapeutics, Inc. /Old/
Relmada Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Relmada Therapeutics, Inc. is a holding company, which engages in the development of pharmaceutical drugs for the treatment of acute and chronic pains. It focuses in the developing of chronic pain due to cancer, musculoskeletal disorders, and peripheral neuropathy. The company was founded in 2000 and is headquartered in Blue Bell, PA. | Health Technology |
| Neurological Association of New Jersey |